Insider Trading › RARE › Insiders
Ultragenyx Pharmaceutical Inc.
RARE·Nasdaq·
United States·Insider activity
United States·Insider activity$14.89
+0.43 (+2.97%)
Close · Oct 7, 2026 · Close Prices from Tiingo.com
RARE
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
RARES&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, RARE insiders filed 0 purchases ($0) and 11 sales ($817K) on the open market, by 6 insiders. Newest filing Sep 15, 2026 (23 days ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by RARE insiders · Form 4 · last two years
On Record
$0Purchases · 180 days
$817KSales · 180 days
486Open-market transactions on record
6Insiders filing · 180 days
Purchases (code P) and sales (code S) of RARE common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
486 on record · newest trade first · the newest 300 shown
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Huizenga Theodore AlanSVP, Chief Accounting Officer | Sale | −1,283 | $13.57 | $17K | 67.9Kdirect | Sep 15, 2026 | Sep 15, 2026 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Chief Accounting Officer | Sale | −161 | $13.99 | $2K | 69.1Kdirect | Sep 3, 2026 | Sep 8, 2026 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and Chief Legal Officer | Sale | −1,900 | $24.92 | $47K | 92.6Kdirect | Aug 3, 2026 | Aug 4, 2026 | Form 4 ↗ |
| Horn HowardChief Financial Officer | Sale | −4,696 | $24.92 | $117K | 96.3Kdirect | Aug 3, 2026 | Aug 4, 2026 | Form 4 ↗ |
| Horn HowardChief Financial Officer | Sale | −4,698 | $33.13 | $156K | 101.0Kdirect | Jul 1, 2026 | Jul 6, 2026 | Form 4 ↗ |
| Sanders Corazon (Corsee) D.Director | Sale | −2,000 | $25.05 | $50K | 21.1Kdirect | Jun 15, 2026 | Jun 15, 2026 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and Chief Legal Officer | Sale | −1,899 | $24.62 | $47K | 94.5Kdirect | Jun 15, 2026 | Jun 15, 2026 | Form 4 ↗ |
| Horn HowardChief Financial Officer | Sale | −4,653 | $23.77 | $111K | 105.7Kdirect | Jun 1, 2026 | Jun 1, 2026 | Form 4 ↗ |
| SULIMAN SHEHNAAZDirector | Sale | −5,740 | $25.12 | $144K | 28.0Kdirect | May 18, 2026 | May 18, 2026 | Form 4 ↗ |
| Crombez EricEVP and Chief Medical Officer | Sale | −344 | $24.96 | $9K | 111.2Kdirect | May 5, 2026 | May 6, 2026 | Form 4 ↗ |
| Horn HowardChief Financial Officer | Sale | −4,683 | $24.90 | $117K | 110.3Kdirect | May 1, 2026 | May 4, 2026 | Form 4 ↗ |
| Horn HowardChief Financial Officer | Sale | −4,683 | $20.97 | $98K | 80.4Kdirect | Apr 1, 2026 | Apr 2, 2026 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and Chief Legal Officer | Sale | −3,508 | $22.67 | $80K | 66.8Kdirect | Mar 10, 2026 | Mar 10, 2026 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and Chief Legal Officer | Sale | −6,018 | $21.40 | $129K | 70.3Kdirect | Mar 6, 2026 | Mar 10, 2026 | Form 4 ↗ |
| Horn HowardChief Financial Officer | Sale | −1,635 | $22.40 | $37K | 85.0Kdirect | Mar 3, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Pinion John RichardSee Remarks | Sale | −10.0K | $22.80 | $229K | 110.0Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Harris ErikEVP & Chief Commercial Officer | Sale | −10.5K | $22.80 | $240K | 89.5Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −54.4K | $22.80 | $1.2M | 659.0Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and Chief Legal Officer | Sale | −8,135 | $22.80 | $185K | 76.3Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Chief Accounting Officer | Sale | −1,632 | $22.80 | $37K | 48.7Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Horn HowardChief Financial Officer | Sale | −3,119 | $22.54 | $70K | 86.7Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Horn HowardChief Financial Officer | Sale | −5,290 | $22.80 | $121K | 89.8Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Crombez EricEVP and Chief Medical Officer | Sale | −7,029 | $22.80 | $160K | 76.3Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Horn HowardChief Financial Officer | Sale | −3,061 | $23.56 | $72K | 88.9Kdirect | Feb 2, 2026 | Feb 3, 2026 | Form 4 ↗ |
| Horn HowardChief Financial Officer | Sale | −3,150 | $22.84 | $72K | 92.0Kdirect | Jan 2, 2026 | Jan 5, 2026 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Chief Accounting Officer | Sale | −85 | $34.38 | $3K | 50.5Kdirect | Dec 29, 2025 | Dec 30, 2025 | Form 4 ↗ |
| Horn HowardChief Financial Officer | Sale | −3,081 | $36.38 | $112K | 95.1Kdirect | Dec 10, 2025 | Dec 11, 2025 | Form 4 ↗ |
| Horn HowardChief Financial Officer | Sale | −7,942 | $31.51 | $250K | 98.2Kdirect | Oct 13, 2025 | Oct 14, 2025 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Chief Accounting Officer | Sale | −64 | $29.17 | $2K | 50.2Kdirect | Sep 18, 2025 | Sep 19, 2025 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and Chief Legal Officer | Sale | −2,450 | $31.17 | $76K | 73.3Kdirect | Sep 12, 2025 | Sep 12, 2025 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Chief Accounting Officer | Sale | −84 | $31.39 | $3K | 50.3Kdirect | Sep 5, 2025 | Sep 8, 2025 | Form 4 ↗ |
| Sanders Corazon (Corsee) D.Director | Sale | −2,405 | $37.39 | $90K | 15.3Kdirect | Jun 20, 2025 | Jun 23, 2025 | Form 4 ↗ |
| Crombez EricEVP and Chief Medical Officer | Sale | −520 | $39.24 | $20K | 71.5Kdirect | May 5, 2025 | May 5, 2025 | Form 4 ↗ |
| Crombez EricEVP and Chief Medical Officer | Sale | −242 | $35.11 | $8K | 71.7Kdirect | Apr 21, 2025 | May 5, 2025 | Form 4 ↗ |
| Horn HowardChief Financial Officer | Sale | −1,785 | $40.40 | $72K | 106.2Kdirect | Mar 6, 2025 | Mar 10, 2025 | Form 4 ↗ |
| Kassberg Thomas RichardCBO & EVP | Sale | −6,028 | $42.10 | $254K | 265.2Kdirect | Mar 3, 2025 | Mar 4, 2025 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and Chief Legal Officer | Sale | −12.8K | $42.10 | $541K | 75.3Kdirect | Mar 3, 2025 | Mar 4, 2025 | Form 4 ↗ |
| Crombez EricEVP and Chief Medical Officer | Sale | −8,945 | $42.10 | $377K | 71.9Kdirect | Mar 3, 2025 | Mar 4, 2025 | Form 4 ↗ |
| Pinion John RichardSee Remarks | Sale | −14.4K | $42.10 | $608K | 107.8Kdirect | Mar 3, 2025 | Mar 4, 2025 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −73.4K | $42.10 | $3.1M | 641.7Kdirect | Mar 3, 2025 | Mar 4, 2025 | Form 4 ↗ |
| Harris ErikEVP & Chief Commercial Officer | Sale | −15.1K | $42.10 | $636K | 87.9Kdirect | Mar 3, 2025 | Mar 4, 2025 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Chief Accounting Officer | Sale | −967 | $42.10 | $41K | 50.3Kdirect | Mar 3, 2025 | Mar 4, 2025 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −25.0K | $42.48 | $1.1M | 2.2Mindirect | Feb 28, 2025 | Mar 4, 2025 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and Chief Legal Officer | Sale | −760 | $42.75 | $32K | 55.0Kdirect | Feb 27, 2025 | Mar 3, 2025 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and Chief Legal Officer | Sale | −2,230 | $42.93 | $96K | 55.8Kdirect | Feb 27, 2025 | Mar 3, 2025 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −11.7K | $42.23 | $495K | 2.2Mindirect | Dec 30, 2024 | Dec 31, 2024 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −8,273 | $50.00 | $414K | 2.2Mindirect | Dec 10, 2024 | Dec 11, 2024 | Form 4 ↗ |
| Horn HowardChief Financial Officer | Sale | −7,465 | $52.76 | $394K | 92.3Kdirect | Oct 10, 2024 | Oct 11, 2024 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −20.0K | $55.85 | $1.1M | 2.2Mindirect | Sep 3, 2024 | Sep 5, 2024 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Chief Accounting Officer | Sale | −91 | $56.19 | $5K | 41.6Kdirect | Sep 3, 2024 | Sep 5, 2024 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −20.0K | $50.17 | $1.0M | 2.2Mindirect | Aug 6, 2024 | Aug 7, 2024 | Form 4 ↗ |
| Sanders Corazon (Corsee) D.Director | Sale | −584 | $40.98 | $24K | 12.0Kdirect | Jul 2, 2024 | Jul 3, 2024 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and Chief Legal Officer | Sale | −9,806 | $45.00 | $441K | 58.0Kdirect | Jun 12, 2024 | Jun 12, 2024 | Form 4 ↗ |
| Sanders Corazon (Corsee) D.Director | Sale | −1,737 | $41.10 | $71K | 7,248direct | Jun 10, 2024 | Jun 10, 2024 | Form 4 ↗ |
| Crombez EricEVP and Chief Medical Officer | Sale | −354 | $43.66 | $15K | 48.4Kdirect | May 2, 2024 | May 3, 2024 | Form 4 ↗ |
| Crombez EricEVP and Chief Medical Officer | Sale | −142 | $44.10 | $6K | 48.8Kdirect | Apr 18, 2024 | Apr 19, 2024 | Form 4 ↗ |
| Kassberg Thomas RichardCBO & EVP | Sale | −11.5K | $49.93 | $575K | 252.8Kdirect | Mar 11, 2024 | Mar 12, 2024 | Form 4 ↗ |
| Fust Matthew KDirector | Sale | −7,500 | $50.88 | $382K | 14.9Kdirect | Mar 7, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Fust Matthew KDirector | Sale | −2,145 | $50.85 | $109K | 22.4Kdirect | Mar 7, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Fust Matthew KDirector | Sale | −2,550 | $50.89 | $130K | 24.5Kdirect | Mar 7, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and Chief Legal Officer | Sale | −3,756 | $53.76 | $202K | 67.3Kdirect | Mar 1, 2024 | Mar 5, 2024 | Form 4 ↗ |
| Kassberg Thomas RichardCBO & EVP | Sale | −1,011 | $53.76 | $54K | 264.3Kdirect | Mar 1, 2024 | Mar 5, 2024 | Form 4 ↗ |
| Pinion John RichardSee Remarks | Sale | −4,173 | $53.76 | $224K | 89.3Kdirect | Mar 1, 2024 | Mar 5, 2024 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Chief Accounting Officer | Sale | −341 | $53.76 | $18K | 41.4Kdirect | Mar 1, 2024 | Mar 5, 2024 | Form 4 ↗ |
| Crombez EricEVP and Chief Medical Officer | Sale | −1,238 | $53.76 | $67K | 48.9Kdirect | Mar 1, 2024 | Mar 5, 2024 | Form 4 ↗ |
| Harris ErikEVP & Chief Commercial Officer | Sale | −4,768 | $53.76 | $256K | 67.2Kdirect | Mar 1, 2024 | Mar 5, 2024 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −30.0K | $45.00 | $1.4M | 539.8Kdirect | Feb 7, 2024 | Feb 8, 2024 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −30.0K | $47.87 | $1.4M | 569.8Kdirect | Dec 29, 2023 | Jan 2, 2024 | Form 4 ↗ |
| Kassberg Thomas RichardCBO & EVP | Sale | −39.9K | $32.78 | $1.3M | 246.9Kdirect | Oct 23, 2023 | Oct 24, 2023 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −47.9K | $33.52 | $1.6M | 599.7Kdirect | Oct 19, 2023 | Oct 23, 2023 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Chief Accounting Officer | Sale | −163 | $38.34 | $6K | 23.6Kdirect | Sep 7, 2023 | Sep 11, 2023 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Chief Accounting Officer | Sale | −2,000 | $41.00 | $82K | 23.8Kdirect | Sep 7, 2023 | Sep 11, 2023 | Form 4 ↗ |
| Harris ErikEVP & Chief Commercial Officer | Sale | −6,000 | $37.96 | $228K | 51.3Kdirect | Sep 5, 2023 | Sep 6, 2023 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Chief Accounting Officer | Sale | −87 | $38.23 | $3K | 23.8Kdirect | Sep 1, 2023 | Sep 6, 2023 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Chief Accounting Officer | Sale | −883 | $37.04 | $33K | 23.9Kdirect | Sep 1, 2023 | Sep 6, 2023 | Form 4 ↗ |
| Sanders Corazon (Corsee) D.Director | Sale | −585 | $46.76 | $27K | 8,985direct | Jun 30, 2023 | Jun 30, 2023 | Form 4 ↗ |
| Harris ErikEVP & Chief Commercial Officer | Sale | −305 | $48.20 | $15K | 57.3Kdirect | Jun 19, 2023 | Jun 21, 2023 | Form 4 ↗ |
| Sanders Corazon (Corsee) D.Director | Sale | −1,485 | $51.65 | $77K | 9,570direct | Jun 8, 2023 | Jun 9, 2023 | Form 4 ↗ |
| Pinion John RichardSee Remarks | Sale | −2,012 | $50.00 | $101K | 74.7Kdirect | May 18, 2023 | May 19, 2023 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and Chief Legal Officer | Sale | −4,378 | $45.00 | $197K | 52.0Kdirect | May 4, 2023 | May 5, 2023 | Form 4 ↗ |
| Bedrosian Camille LEVP and Chief Medical Officer | Sale | −3,881 | $45.25 | $176K | 46.7Kdirect | Mar 1, 2023 | Mar 3, 2023 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and Chief Legal Officer | Sale | −3,161 | $45.25 | $143K | 56.1Kdirect | Mar 1, 2023 | Mar 3, 2023 | Form 4 ↗ |
| Kassberg Thomas RichardCBO & EVP | Sale | −1,968 | $45.27 | $89K | 250.3Kdirect | Mar 1, 2023 | Mar 3, 2023 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Chief Accounting Officer | Sale | −100 | $45.65 | $5K | 23.0Kdirect | Mar 1, 2023 | Mar 3, 2023 | Form 4 ↗ |
| Huang Dennis KarlSee Remarks | Sale | −389 | $45.65 | $18K | 75.3Kdirect | Mar 1, 2023 | Mar 3, 2023 | Form 4 ↗ |
| Pinion John RichardSee Remarks | Sale | −3,755 | $45.26 | $170K | 80.2Kdirect | Mar 1, 2023 | Mar 3, 2023 | Form 4 ↗ |
| Harris ErikEVP & Chief Commercial Officer | Sale | −3,664 | $45.25 | $166K | 57.3Kdirect | Mar 1, 2023 | Mar 3, 2023 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Chief Accounting Officer | Sale | −639 | $43.40 | $28K | 15.6Kdirect | Feb 28, 2023 | Mar 2, 2023 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −19.6K | $45.57 | $892K | 541.1Kdirect | Dec 30, 2022 | Jan 3, 2023 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Chief Accounting Officer | Sale | −2,031 | $43.96 | $89K | 16.2Kdirect | Dec 21, 2022 | Dec 22, 2022 | Form 4 ↗ |
| Dier MardiCFO & Executive Vice President | Sale | −1,629 | $40.16 | $65K | 66.7Kdirect | Oct 14, 2022 | Oct 17, 2022 | Form 4 ↗ |
| Dier MardiCFO & Executive Vice President | Sale | −3,484 | $38.22 | $133K | 68.3Kdirect | Oct 12, 2022 | Oct 14, 2022 | Form 4 ↗ |
| Harris ErikEVP & Chief Commercial Officer | Sale | −295 | $54.78 | $16K | 36.2Kdirect | Jun 19, 2022 | Jun 22, 2022 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Chief Accounting Officer | Sale | −132 | $84.55 | $11K | 16.9Kdirect | Apr 16, 2022 | Apr 19, 2022 | Form 4 ↗ |
| Kassberg Thomas RichardCBO & EVP | Sale | −10.3K | $67.01 | $689K | 227.6Kdirect | Mar 11, 2022 | Mar 15, 2022 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and Chief Legal Officer | Sale | −5,140 | $62.95 | $324K | 34.4Kdirect | Mar 7, 2022 | Mar 8, 2022 | Form 4 ↗ |
| Dier MardiCFO & Executive Vice President | Sale | −420 | $64.55 | $27K | 51.8Kdirect | Mar 3, 2022 | Mar 3, 2022 | Form 4 ↗ |
| Dier MardiCFO & Executive Vice President | Sale | −534 | $66.62 | $36K | 38.2Kdirect | Mar 1, 2022 | Mar 3, 2022 | Form 4 ↗ |
| Harris ErikEVP & Chief Commercial Officer | Sale | −2,713 | $66.62 | $181K | 22.3Kdirect | Mar 1, 2022 | Mar 3, 2022 | Form 4 ↗ |
| Pinion John RichardSee Remarks | Sale | −4,498 | $66.62 | $300K | 45.3Kdirect | Mar 1, 2022 | Mar 3, 2022 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Chief Accounting Officer | Sale | −843 | $66.62 | $56K | 13.2Kdirect | Mar 1, 2022 | Mar 3, 2022 | Form 4 ↗ |
| Huang Dennis KarlSee Remarks | Sale | −3,234 | $66.62 | $215K | 36.9Kdirect | Mar 1, 2022 | Mar 3, 2022 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and Chief Legal Officer | Sale | −2,886 | $66.62 | $192K | 25.5Kdirect | Mar 1, 2022 | Mar 3, 2022 | Form 4 ↗ |
| Kassberg Thomas RichardCBO & EVP | Sale | −2,374 | $66.62 | $158K | 213.8Kdirect | Mar 1, 2022 | Mar 3, 2022 | Form 4 ↗ |
| Bedrosian Camille LEVP and Chief Medical Officer | Sale | −2,821 | $66.62 | $188K | 33.9Kdirect | Mar 1, 2022 | Mar 3, 2022 | Form 4 ↗ |
| Bedrosian Camille LEVP and Chief Medical Officer | Sale | −1,657 | $66.30 | $110K | 36.8Kdirect | Jan 30, 2022 | Feb 1, 2022 | Form 4 ↗ |
| Bedrosian Camille LEVP and Chief Medical Officer | Sale | −359 | $81.14 | $29K | 38.4Kdirect | Oct 14, 2021 | Oct 18, 2021 | Form 4 ↗ |
| Harris ErikEVP & Chief Commercial Officer | Sale | −303 | $81.14 | $25K | 25.0Kdirect | Oct 14, 2021 | Oct 18, 2021 | Form 4 ↗ |
| Huang Dennis KarlEVP & Chief Tech Ops Officer | Sale | −358 | $81.14 | $29K | 40.1Kdirect | Oct 14, 2021 | Oct 18, 2021 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Chief Accounting Officer | Sale | −140 | $81.14 | $11K | 14.1Kdirect | Oct 14, 2021 | Oct 18, 2021 | Form 4 ↗ |
| Kassberg Thomas RichardCBO & EVP | Sale | −286 | $81.14 | $23K | 216.3Kdirect | Oct 14, 2021 | Oct 18, 2021 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and General Counsel | Sale | −310 | $81.14 | $25K | 28.4Kdirect | Oct 14, 2021 | Oct 18, 2021 | Form 4 ↗ |
| Pinion John RichardSee Remarks | Sale | −358 | $81.14 | $29K | 49.8Kdirect | Oct 14, 2021 | Oct 18, 2021 | Form 4 ↗ |
| Dier MardiCFO & Executive Vice President | Sale | −3,261 | $81.16 | $265K | 38.8Kdirect | Oct 14, 2021 | Oct 14, 2021 | Form 4 ↗ |
| Dier MardiCFO & Executive Vice President | Sale | −3,477 | $82.79 | $288K | 42.0Kdirect | Oct 12, 2021 | Oct 14, 2021 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and General Counsel | Sale | −7,336 | $100.65 | $738K | 28.7Kdirect | Sep 8, 2021 | Sep 9, 2021 | Form 4 ↗ |
| Bedrosian Camille LEVP and Chief Medical Officer | Sale | −2,500 | $100.18 | $250K | 38.8Kdirect | Sep 2, 2021 | Sep 2, 2021 | Form 4 ↗ |
| Bedrosian Camille LEVP and Chief Medical Officer | Sale | −2,500 | $100.03 | $250K | 38.8Kdirect | Sep 1, 2021 | Sep 2, 2021 | Form 4 ↗ |
| Harris ErikEVP & Chief Commercial Officer | Sale | −375 | $91.53 | $34K | 25.3Kdirect | Jul 6, 2021 | Jul 8, 2021 | Form 4 ↗ |
| Harris ErikEVP & Chief Commercial Officer | Sale | −572 | $94.96 | $54K | 25.7Kdirect | Jun 21, 2021 | Jun 23, 2021 | Form 4 ↗ |
| Harris ErikEVP & Chief Commercial Officer | Sale | −437 | $94.63 | $41K | 26.3Kdirect | Jun 19, 2021 | Jun 23, 2021 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and General Counsel | Sale | −1,329 | $100.00 | $133K | 28.7Kdirect | Jun 10, 2021 | Jun 11, 2021 | Form 4 ↗ |
| Harris ErikEVP & Chief Commercial Officer | Sale | −393 | $113.67 | $45K | 26.7Kdirect | May 7, 2021 | May 10, 2021 | Form 4 ↗ |
| Huang Dennis KarlEVP & Chief Tech Ops Officer | Sale | −363 | $113.68 | $41K | 40.5Kdirect | May 6, 2021 | May 10, 2021 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and General Counsel | Sale | −313 | $113.67 | $36K | 30.0Kdirect | May 6, 2021 | May 10, 2021 | Form 4 ↗ |
| Pinion John RichardSee Remarks | Sale | −363 | $113.69 | $41K | 50.1Kdirect | May 6, 2021 | May 10, 2021 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Chief Accounting Officer | Sale | −142 | $113.67 | $16K | 15.0Kdirect | May 6, 2021 | May 10, 2021 | Form 4 ↗ |
| Kassberg Thomas RichardCBO & EVP | Sale | −363 | $113.69 | $41K | 106.8Kdirect | May 6, 2021 | May 10, 2021 | Form 4 ↗ |
| Harris ErikEVP & Chief Commercial Officer | Sale | −307 | $113.68 | $35K | 27.1Kdirect | May 6, 2021 | May 10, 2021 | Form 4 ↗ |
| Bedrosian Camille LEVP and Chief Medical Officer | Sale | −364 | $113.67 | $41K | 38.8Kdirect | May 6, 2021 | May 10, 2021 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −30.0K | $107.80 | $3.2M | 2.3Mindirect | May 3, 2021 | May 5, 2021 | Form 4 ↗ |
| Harris ErikEVP & Chief Commercial Officer | Sale | −396 | $104.28 | $41K | 27.4Kdirect | Apr 20, 2021 | Apr 21, 2021 | Form 4 ↗ |
| Bedrosian Camille LEVP and Chief Medical Officer | Sale | −5,000 | $109.09 | $545K | 39.1Kdirect | Apr 15, 2021 | Apr 19, 2021 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Controller and PAO | Sale | −3,000 | $120.69 | $362K | 13.5Kdirect | Mar 8, 2021 | Mar 9, 2021 | Form 4 ↗ |
| Harris ErikEVP & Chief Commercial Officer | Sale | −707 | $138.16 | $98K | 27.8Kdirect | Mar 2, 2021 | Mar 3, 2021 | Form 4 ↗ |
| Kassberg Thomas RichardCBO & EVP | Sale | −4,572 | $138.17 | $632K | 107.2Kdirect | Mar 1, 2021 | Mar 3, 2021 | Form 4 ↗ |
| Pinion John RichardSee Remarks | Sale | −6,198 | $138.17 | $856K | 50.2Kdirect | Mar 1, 2021 | Mar 3, 2021 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and General Counsel | Sale | −3,970 | $138.17 | $549K | 30.2Kdirect | Mar 1, 2021 | Mar 3, 2021 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Controller and PAO | Sale | −732 | $138.17 | $101K | 16.5Kdirect | Mar 1, 2021 | Mar 3, 2021 | Form 4 ↗ |
| Harris ErikEVP & Chief Commercial Officer | Sale | −2,470 | $138.17 | $341K | 28.5Kdirect | Mar 1, 2021 | Mar 3, 2021 | Form 4 ↗ |
| Huang Dennis KarlEVP & Chief Tech Ops Officer | Sale | −4,255 | $138.18 | $588K | 40.8Kdirect | Mar 1, 2021 | Mar 3, 2021 | Form 4 ↗ |
| Bedrosian Camille LEVP and Chief Medical Officer | Sale | −4,543 | $138.18 | $628K | 39.1Kdirect | Mar 1, 2021 | Mar 3, 2021 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −30.0K | $141.80 | $4.3M | 2.3Mindirect | Mar 1, 2021 | Mar 3, 2021 | Form 4 ↗ |
| Aliski WilliamDirector | Sale | −7,500 | $149.01 | $1.1M | 65.7Kdirect | Feb 19, 2021 | Feb 23, 2021 | Form 4 ↗ |
| Bedrosian Camille LEVP and Chief Medical Officer | Sale | −2,243 | $140.36 | $315K | 33.5Kdirect | Jan 30, 2021 | Feb 2, 2021 | Form 4 ↗ |
| Bedrosian Camille LEVP and Chief Medical Officer | Sale | −25.0K | $139.18 | $3.5M | 35.8Kdirect | Jan 15, 2021 | Jan 19, 2021 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Controller and PAO | Sale | −4,000 | $140.65 | $563K | 15.7Kdirect | Jan 7, 2021 | Jan 8, 2021 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −30.0K | $136.90 | $4.1M | 2.3Mindirect | Jan 4, 2021 | Jan 5, 2021 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −30.0K | $96.82 | $2.9M | 2.4Mindirect | Nov 2, 2020 | Nov 4, 2020 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and General Counsel | Sale | −9,903 | $100.12 | $991K | 24.1Kdirect | Oct 30, 2020 | Nov 2, 2020 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and General Counsel | Sale | −97 | $100.00 | $10K | 24.0Kdirect | Oct 28, 2020 | Oct 30, 2020 | Form 4 ↗ |
| Bedrosian Camille LEVP and Chief Medical Officer | Sale | −262 | $88.00 | $23K | 35.8Kdirect | Oct 14, 2020 | Oct 16, 2020 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and General Counsel | Sale | −325 | $88.00 | $29K | 24.0Kdirect | Oct 14, 2020 | Oct 16, 2020 | Form 4 ↗ |
| Kassberg Thomas RichardCBO & EVP | Sale | −262 | $87.98 | $23K | 101.5Kdirect | Oct 14, 2020 | Oct 16, 2020 | Form 4 ↗ |
| Harris ErikEVP & Chief Commercial Officer | Sale | −220 | $88.00 | $19K | 23.4Kdirect | Oct 14, 2020 | Oct 16, 2020 | Form 4 ↗ |
| Pinion John RichardSee Remarks | Sale | −262 | $88.00 | $23K | 46.3Kdirect | Oct 14, 2020 | Oct 16, 2020 | Form 4 ↗ |
| Huang Dennis KarlEVP & Chief Tech Ops Officer | Sale | −262 | $88.00 | $23K | 34.7Kdirect | Oct 14, 2020 | Oct 16, 2020 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Controller and PAO | Sale | −146 | $87.98 | $13K | 16.4Kdirect | Oct 14, 2020 | Oct 16, 2020 | Form 4 ↗ |
| Sharp ShaliniEVP, Finance | Sale | −375 | $87.99 | $33K | 97.8Kdirect | Oct 14, 2020 | Oct 16, 2020 | Form 4 ↗ |
| Pinion John RichardSee Remarks | Sale | −2,780 | $94.47 | $263K | 46.6Kdirect | Oct 12, 2020 | Oct 13, 2020 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and General Counsel | Sale | −10.0K | $95.00 | $950K | 24.3Kdirect | Oct 8, 2020 | Oct 13, 2020 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and General Counsel | Sale | −10.0K | $90.00 | $900K | 24.3Kdirect | Oct 6, 2020 | Oct 7, 2020 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and General Counsel | Sale | −10.0K | $85.00 | $850K | 24.3Kdirect | Sep 23, 2020 | Sep 24, 2020 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −30.0K | $82.63 | $2.5M | 2.4Mindirect | Sep 1, 2020 | Sep 2, 2020 | Form 4 ↗ |
| Aliski WilliamDirector | Sale | −5,000 | $86.57 | $433K | 57.0Kdirect | Aug 21, 2020 | Aug 25, 2020 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and General Counsel | Sale | −2,370 | $88.39 | $209K | 24.3Kdirect | Aug 17, 2020 | Aug 19, 2020 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and General Counsel | Sale | −10.0K | $88.44 | $884K | 26.7Kdirect | Aug 17, 2020 | Aug 19, 2020 | Form 4 ↗ |
| Sharp ShaliniCFO & Executive Vice President | Sale | −3,669 | $88.38 | $324K | 98.2Kdirect | Aug 17, 2020 | Aug 19, 2020 | Form 4 ↗ |
| Sharp ShaliniCFO & Executive Vice President | Sale | −7,188 | $88.38 | $635K | 98.2Kdirect | Aug 17, 2020 | Aug 19, 2020 | Form 4 ↗ |
| Sharp ShaliniCFO & Executive Vice President | Sale | −500 | $88.38 | $44K | 98.2Kdirect | Aug 17, 2020 | Aug 19, 2020 | Form 4 ↗ |
| Sharp ShaliniCFO & Executive Vice President | Sale | −2,560 | $88.54 | $227K | 98.2Kdirect | Aug 17, 2020 | Aug 19, 2020 | Form 4 ↗ |
| Sharp ShaliniCFO & Executive Vice President | Sale | −461 | $88.24 | $41K | 100.7Kdirect | Aug 17, 2020 | Aug 19, 2020 | Form 4 ↗ |
| SIEGALL CLAY BDirector | Sale | −1,596 | $85.01 | $136K | 2,550direct | Aug 10, 2020 | Aug 11, 2020 | Form 4 ↗ |
| SIEGALL CLAY BDirector | Sale | −9,750 | $85.01 | $829K | 2,550direct | Aug 10, 2020 | Aug 11, 2020 | Form 4 ↗ |
| SIEGALL CLAY BDirector | Sale | −23.4K | $85.55 | $2.0M | 12.3Kdirect | Aug 7, 2020 | Aug 11, 2020 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −40.0K | $85.35 | $3.4M | 2.4Mindirect | Jul 13, 2020 | Jul 15, 2020 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Controller and PAO | Sale | −2,000 | $91.00 | $182K | 16.6Kdirect | Jul 8, 2020 | Jul 10, 2020 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Controller and PAO | Sale | −638 | $91.00 | $58K | 16.6Kdirect | Jul 8, 2020 | Jul 10, 2020 | Form 4 ↗ |
| Fust Matthew KDirector | Sale | −6,181 | $90.00 | $556K | 13.6Kdirect | Jul 6, 2020 | Jul 8, 2020 | Form 4 ↗ |
| Fust Matthew KDirector | Sale | −5,000 | $85.00 | $425K | 13.6Kdirect | Jul 1, 2020 | Jul 6, 2020 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Controller and PAO | Sale | −1,500 | $81.00 | $122K | 17.2Kdirect | Jul 1, 2020 | Jul 6, 2020 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Controller and PAO | Sale | −1,111 | $81.00 | $90K | 17.2Kdirect | Jul 1, 2020 | Jul 6, 2020 | Form 4 ↗ |
| Sharp ShaliniCFO & Executive Vice President | Sale | −2,564 | $74.01 | $190K | 101.2Kdirect | Jun 4, 2020 | Jun 5, 2020 | Form 4 ↗ |
| Harris ErikEVP & Chief Commercial Officer | Sale | −2,516 | $74.69 | $188K | 20.9Kdirect | Jun 3, 2020 | Feb 3, 2021 | Form 4 ↗ |
| Sharp ShaliniCFO & Executive Vice President | Sale | −10.2K | $74.23 | $760K | 101.2Kdirect | Jun 3, 2020 | Jun 5, 2020 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Controller and PAO | Sale | −260 | $74.93 | $19K | 18.3Kdirect | May 26, 2020 | May 27, 2020 | Form 4 ↗ |
| Sharp ShaliniCFO & Executive Vice President | Sale | −3,907 | $73.32 | $286K | 101.6Kdirect | May 19, 2020 | May 20, 2020 | Form 4 ↗ |
| Sharp ShaliniCFO & Executive Vice President | Sale | −3,221 | $73.32 | $236K | 100.9Kdirect | May 19, 2020 | May 20, 2020 | Form 4 ↗ |
| Aliski WilliamDirector | Sale | −20.0K | $74.02 | $1.5M | 70.3Kindirect | May 18, 2020 | Jun 3, 2020 | Form 4 ↗ |
| Aliski WilliamDirector | Sale | −7,500 | $74.65 | $560K | 47.9Kdirect | May 18, 2020 | May 20, 2020 | Form 4 ↗ |
| Sharp ShaliniCFO & Executive Vice President | Sale | −2,392 | $73.29 | $175K | 100.9Kdirect | May 18, 2020 | May 20, 2020 | Form 4 ↗ |
| Sharp ShaliniCFO & Executive Vice President | Sale | −19.6K | $73.34 | $1.4M | 103.3Kdirect | May 18, 2020 | May 20, 2020 | Form 4 ↗ |
| Fust Matthew KDirector | Sale | −1,875 | $75.00 | $141K | 11.0Kdirect | May 18, 2020 | May 19, 2020 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and General Counsel | Sale | −2,722 | $74.72 | $203K | 27.3Kdirect | May 18, 2020 | May 19, 2020 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Controller and PAO | Sale | −1,500 | $71.00 | $107K | 19.0Kdirect | May 15, 2020 | May 19, 2020 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Controller and PAO | Sale | −961 | $71.00 | $68K | 18.7Kdirect | May 15, 2020 | May 19, 2020 | Form 4 ↗ |
| Fust Matthew KDirector | Sale | −1,875 | $65.00 | $122K | 12.9Kdirect | Apr 22, 2020 | Apr 24, 2020 | Form 4 ↗ |
| Huizenga Theodore AlanSVP, Controller and PAO | Sale | −1,000 | $61.00 | $61K | 15.9Kdirect | Jan 14, 2020 | Jan 15, 2020 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Purchase | +5,000 | $43.63 | $218K | 472.5Kdirect | Sep 11, 2019 | Sep 11, 2019 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and General Counsel | Sale | −1,226 | $61.50 | $75K | 17.6Kdirect | Jun 24, 2019 | Jun 24, 2019 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and General Counsel | Sale | −1,489 | $63.01 | $94K | 18.9Kdirect | Jun 21, 2019 | Jun 24, 2019 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and General Counsel | Sale | −468 | $68.30 | $32K | 19.6Kdirect | Apr 29, 2019 | Apr 30, 2019 | Form 4 ↗ |
| Sharp ShaliniCFO & Executive Vice President | Sale Amended | −14.8K | $70.00 | $1.0M | 66.3Kdirect | Mar 18, 2019 | Apr 17, 2019 | Form 4 ↗ |
| Sharp ShaliniCFO & Executive Vice President | Sale | −14.8K | $70.00 | $1.0M | 66.4Kdirect | Mar 18, 2019 | Mar 20, 2019 | Form 4 ↗ |
| Kassberg Thomas RichardCBO & EVP | Sale Amended | −832 | $65.52 | $55K | 89.5Kdirect | Mar 5, 2019 | Apr 17, 2019 | Form 4 ↗ |
| Huizenga Theodore AlanVP, Controller and PAO | Sale Amended | −254 | $65.52 | $17K | 15.6Kdirect | Mar 5, 2019 | Apr 17, 2019 | Form 4 ↗ |
| Huang Dennis KarlEVP & Chief Tech Ops Officer | Sale Amended | −626 | $65.52 | $41K | 21.7Kdirect | Mar 5, 2019 | Apr 17, 2019 | Form 4 ↗ |
| Pinion John RichardSee Remarks | Sale Amended | −722 | $65.52 | $47K | 37.0Kdirect | Mar 5, 2019 | Apr 17, 2019 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and General Counsel | Sale Amended | −886 | $65.52 | $58K | 20.3Kdirect | Mar 5, 2019 | Apr 17, 2019 | Form 4 ↗ |
| Sharp ShaliniCFO & Executive Vice President | Sale Amended | −1,012 | $65.52 | $66K | 69.1Kdirect | Mar 5, 2019 | Apr 17, 2019 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale Amended | −2,890 | $65.52 | $189K | 467.6Kdirect | Mar 5, 2019 | Apr 17, 2019 | Form 4 ↗ |
| Aliski WilliamDirector | Sale | −6,000 | $49.69 | $298K | 90.3Kindirect | Dec 7, 2018 | Dec 7, 2018 | Form 4 ↗ |
| Aliski WilliamDirector | Sale | −6,000 | $55.67 | $334K | 96.3Kindirect | Nov 8, 2018 | Nov 8, 2018 | Form 4 ↗ |
| Aliski WilliamDirector | Sale | −6,000 | $73.38 | $440K | 102.3Kindirect | Oct 8, 2018 | Oct 9, 2018 | Form 4 ↗ |
| Sharp ShaliniCFO & Executive Vice President | Sale | −6,700 | $90.07 | $603K | 50.1Kdirect | Sep 25, 2018 | Sep 27, 2018 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and General Counsel | Sale Amended | −5,000 | $78.53 | $393K | 14.2Kdirect | Aug 21, 2018 | Oct 9, 2018 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and General Counsel | Sale | −5,000 | $78.53 | $393K | 9,181direct | Aug 21, 2018 | Aug 21, 2018 | Form 4 ↗ |
| Aliski WilliamDirector | Sale | −3,750 | $76.66 | $287K | 72.6Kdirect | Aug 8, 2018 | Aug 8, 2018 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and General Counsel | Sale | −1,226 | $82.77 | $101K | 14.2Kdirect | Jun 21, 2018 | Jun 21, 2018 | Form 4 ↗ |
| Huizenga Theodore AlanVP, Controller and PAO | Sale | −955 | $83.70 | $80K | 11.9Kdirect | Jun 15, 2018 | Jun 15, 2018 | Form 4 ↗ |
| Huizenga Theodore AlanVP, Controller and PAO | Sale | −1,338 | $76.97 | $103K | 9,940direct | Jun 13, 2018 | Jun 13, 2018 | Form 4 ↗ |
| Sharp ShaliniCFO & Executive Vice President | Sale | −6,700 | $80.07 | $536K | 53.5Kdirect | Jun 7, 2018 | Jun 7, 2018 | Form 4 ↗ |
| Sharp ShaliniCFO & Executive Vice President | Sale | −13.0K | $70.17 | $912K | 57.2Kdirect | May 30, 2018 | May 30, 2018 | Form 4 ↗ |
| Fust Matthew KDirector | Sale | −6,319 | $72.00 | $455K | 8,750direct | May 30, 2018 | May 30, 2018 | Form 4 ↗ |
| Parschauer Karah HerdmanEVP and General Counsel | Sale | −1,465 | $60.00 | $88K | 16.1Kdirect | May 10, 2018 | May 10, 2018 | Form 4 ↗ |
| Aliski WilliamDirector | Sale | −650 | $53.97 | $35K | 108.3Kindirect | Apr 19, 2018 | Oct 9, 2018 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Purchase | +1,647 | $52.96 | $87K | 2.6Mindirect | Aug 28, 2017 | Aug 29, 2017 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Purchase | +5,853 | $52.40 | $307K | 2.6Mindirect | Aug 28, 2017 | Aug 29, 2017 | Form 4 ↗ |
| Huizenga Theodore AlanVP, Controller and PAO | Sale | −480 | $57.46 | $28K | 9,366direct | May 26, 2017 | May 26, 2017 | Form 4 ↗ |
| Huizenga Theodore AlanController and PAO | Sale | −2,500 | $86.34 | $216K | 9,709direct | Mar 9, 2017 | Mar 10, 2017 | Form 4 ↗ |
| Sharp ShaliniCFO & Executive Vice President | Sale | −12.0K | $90.10 | $1.1M | 55.9Kdirect | Mar 2, 2017 | Mar 3, 2017 | Form 4 ↗ |
| Sharp ShaliniCFO & Executive Vice President | Sale | −12.0K | $80.14 | $962K | 51.9Kdirect | Feb 27, 2017 | Feb 28, 2017 | Form 4 ↗ |
| Aliski WilliamDirector | Sale | −2,000 | $78.70 | $157K | 60.0Kdirect | Dec 5, 2016 | Dec 5, 2016 | Form 4 ↗ |
| Aliski WilliamDirector | Sale | −4,000 | $77.94 | $312K | 62.0Kdirect | Dec 5, 2016 | Dec 5, 2016 | Form 4 ↗ |
| Huizenga Theodore AlanController and PAO | Sale | −2,000 | $79.73 | $159K | 11.1Kdirect | Nov 16, 2016 | Nov 18, 2016 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −200 | $83.01 | $17K | 447.1Kdirect | Nov 15, 2016 | Nov 17, 2016 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −4,180 | $82.36 | $344K | 447.3Kdirect | Nov 15, 2016 | Nov 17, 2016 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −7,755 | $81.55 | $632K | 451.5Kdirect | Nov 15, 2016 | Nov 17, 2016 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −6,451 | $80.64 | $520K | 459.3Kdirect | Nov 15, 2016 | Nov 17, 2016 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −1,414 | $79.39 | $112K | 465.7Kdirect | Nov 15, 2016 | Nov 17, 2016 | Form 4 ↗ |
| Sharp ShaliniCFO & Executive Vice President | Sale | −700 | $74.34 | $52K | 45.4Kdirect | Nov 9, 2016 | Nov 10, 2016 | Form 4 ↗ |
| Sharp ShaliniCFO & Executive Vice President | Sale | −2,600 | $73.65 | $191K | 46.1Kdirect | Nov 9, 2016 | Nov 10, 2016 | Form 4 ↗ |
| Sharp ShaliniCFO & Executive Vice President | Sale | −3,205 | $72.81 | $233K | 48.7Kdirect | Nov 9, 2016 | Nov 10, 2016 | Form 4 ↗ |
| Sharp ShaliniCFO & Executive Vice President | Sale | −3,895 | $71.68 | $279K | 51.9Kdirect | Nov 9, 2016 | Nov 10, 2016 | Form 4 ↗ |
| Sharp ShaliniCFO & Executive Vice President | Sale | −13.6K | $70.06 | $953K | 55.8Kdirect | Nov 9, 2016 | Nov 10, 2016 | Form 4 ↗ |
| Sharp ShaliniCFO & Senior Vice President | Sale | −6,932 | $61.71 | $428K | 45.4Kdirect | Oct 19, 2016 | Oct 21, 2016 | Form 4 ↗ |
| Sharp ShaliniCFO & Senior Vice President | Sale | −5,068 | $60.98 | $309K | 52.3Kdirect | Oct 19, 2016 | Oct 21, 2016 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −1,800 | $64.78 | $117K | 467.1Kdirect | Oct 14, 2016 | Oct 18, 2016 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −2,345 | $64.41 | $151K | 468.9Kdirect | Oct 14, 2016 | Oct 18, 2016 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −9,340 | $63.06 | $589K | 471.3Kdirect | Oct 14, 2016 | Oct 18, 2016 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −6,515 | $61.97 | $404K | 480.6Kdirect | Oct 14, 2016 | Oct 18, 2016 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −6,097 | $68.12 | $415K | 487.1Kdirect | Aug 15, 2016 | Aug 17, 2016 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −13.9K | $67.39 | $937K | 493.2Kdirect | Aug 15, 2016 | Aug 17, 2016 | Form 4 ↗ |
| AGARWAL SUNILChief Medical Officer | Sale | −649 | $52.68 | $34K | 9,528direct | Jul 21, 2016 | Jul 21, 2016 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −6,450 | $51.34 | $331K | 507.1Kdirect | Jul 15, 2016 | Jul 19, 2016 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −13.6K | $50.61 | $686K | 513.6Kdirect | Jul 15, 2016 | Jul 19, 2016 | Form 4 ↗ |
| AGARWAL SUNILChief Medical Officer | Sale | −650 | $54.16 | $35K | 10.6Kdirect | Jun 20, 2016 | Jun 21, 2016 | Form 4 ↗ |
| AGARWAL SUNILChief Medical Officer | Sale | −650 | $66.00 | $43K | 7,111direct | May 24, 2016 | May 26, 2016 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −200 | $61.93 | $12K | 517.5Kdirect | May 16, 2016 | May 18, 2016 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −2,595 | $61.34 | $159K | 517.7Kdirect | May 16, 2016 | May 18, 2016 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −6,390 | $60.32 | $385K | 520.3Kdirect | May 16, 2016 | May 18, 2016 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −10.8K | $59.37 | $642K | 526.7Kdirect | May 16, 2016 | May 18, 2016 | Form 4 ↗ |
| AGARWAL SUNILChief Medical Officer | Sale | −649 | $70.53 | $46K | 8,567direct | Apr 20, 2016 | Apr 21, 2016 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −5,376 | $71.06 | $382K | 537.5Kdirect | Apr 15, 2016 | Apr 19, 2016 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −9,834 | $70.35 | $692K | 542.9Kdirect | Apr 15, 2016 | Apr 19, 2016 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −4,790 | $69.46 | $333K | 552.7Kdirect | Apr 15, 2016 | Apr 19, 2016 | Form 4 ↗ |
| AGARWAL SUNILChief Medical Officer | Sale | −650 | $61.45 | $40K | 9,608direct | Mar 22, 2016 | Mar 24, 2016 | Form 4 ↗ |
| AGARWAL SUNILChief Medical Officer | Sale | −658 | $63.48 | $42K | 10.7Kdirect | Feb 22, 2016 | Feb 23, 2016 | Form 4 ↗ |
| AGARWAL SUNILChief Medical Officer | Sale | −585 | $72.83 | $43K | 12.2Kdirect | Jan 20, 2016 | Jan 21, 2016 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −605 | $114.61 | $69K | 575.6Kdirect | Dec 31, 2015 | Jan 4, 2016 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −2,702 | $113.83 | $308K | 576.2Kdirect | Dec 31, 2015 | Jan 4, 2016 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −2,191 | $112.91 | $247K | 578.9Kdirect | Dec 31, 2015 | Jan 4, 2016 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −2,600 | $116.31 | $302K | 581.1Kdirect | Dec 30, 2015 | Jan 4, 2016 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −3,600 | $115.56 | $416K | 583.7Kdirect | Dec 30, 2015 | Jan 4, 2016 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −5,465 | $114.61 | $626K | 587.3Kdirect | Dec 30, 2015 | Jan 4, 2016 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −2,837 | $113.30 | $321K | 592.8Kdirect | Dec 30, 2015 | Jan 4, 2016 | Form 4 ↗ |
| AGARWAL SUNILChief Medical Officer | Sale | −498 | $114.81 | $57K | 13.2Kdirect | Dec 22, 2015 | Dec 24, 2015 | Form 4 ↗ |
| Huizenga Theodore AlanController and PAO | Sale | −1,500 | $110.55 | $166K | 2,500direct | Dec 18, 2015 | Dec 18, 2015 | Form 4 ↗ |
| Sharp ShaliniCFO & Senior Vice President | Sale | −5,277 | $101.03 | $533K | 41.8Kdirect | Dec 10, 2015 | Dec 14, 2015 | Form 4 ↗ |
| Sharp ShaliniCFO & Senior Vice President | Sale | −6,723 | $102.16 | $687K | 47.1Kdirect | Dec 10, 2015 | Dec 14, 2015 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −1,415 | $99.42 | $141K | 595.6Kdirect | Nov 30, 2015 | Dec 2, 2015 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −11.4K | $98.62 | $1.1M | 597.1Kdirect | Nov 30, 2015 | Dec 2, 2015 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −5,261 | $97.88 | $515K | 608.4Kdirect | Nov 30, 2015 | Dec 2, 2015 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −1,950 | $96.46 | $188K | 613.7Kdirect | Nov 30, 2015 | Dec 2, 2015 | Form 4 ↗ |
| AGARWAL SUNILChief Medical Officer | Sale | −498 | $95.88 | $48K | 13.8Kdirect | Nov 23, 2015 | Nov 24, 2015 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −1,900 | $101.20 | $192K | 615.6Kdirect | Oct 30, 2015 | Nov 3, 2015 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −4,400 | $100.43 | $442K | 617.5Kdirect | Oct 30, 2015 | Nov 3, 2015 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −7,600 | $99.42 | $756K | 621.9Kdirect | Oct 30, 2015 | Nov 3, 2015 | Form 4 ↗ |
| KAKKIS EMIL DPresident & CEO · Director | Sale | −6,100 | $98.63 | $602K | 629.5Kdirect | Oct 30, 2015 | Nov 3, 2015 | Form 4 ↗ |
| AGARWAL SUNILChief Medical Officer | Sale | −649 | $85.51 | $55K | 14.8Kdirect | Oct 20, 2015 | Oct 21, 2015 | Form 4 ↗ |
| AGARWAL SUNILChief Medical Officer | Sale | −498 | $109.51 | $55K | 15.9Kdirect | Sep 22, 2015 | Sep 24, 2015 | Form 4 ↗ |
| AGARWAL SUNILChief Medical Officer | Sale | −930 | $111.90 | $104K | 16.9Kdirect | Aug 20, 2015 | Aug 21, 2015 | Form 4 ↗ |
| AGARWAL SUNILChief Medical Officer | Sale | −2,000 | $111.21 | $222K | 17.8Kdirect | Aug 20, 2015 | Aug 21, 2015 | Form 4 ↗ |
| AGARWAL SUNILChief Medical Officer | Sale | −4,875 | $110.40 | $538K | 19.8Kdirect | Aug 20, 2015 | Aug 21, 2015 | Form 4 ↗ |
| AGARWAL SUNILChief Medical Officer | Sale | −1,471 | $108.98 | $160K | 24.7Kdirect | Aug 20, 2015 | Aug 21, 2015 | Form 4 ↗ |
| AGARWAL SUNILChief Medical Officer | Sale | −724 | $107.30 | $78K | 26.2Kdirect | Aug 20, 2015 | Aug 21, 2015 | Form 4 ↗ |
| AGARWAL SUNILChief Medical Officer | Sale | −3,650 | $112.73 | $411K | 16.9Kdirect | Aug 20, 2015 | Aug 21, 2015 | Form 4 ↗ |
| AGARWAL SUNILChief Medical Officer | Sale | −3,370 | $112.19 | $378K | 20.6Kdirect | Aug 20, 2015 | Aug 21, 2015 | Form 4 ↗ |
| Kassberg Thomas RichardCBO & Senior Vice President | Sale | −3,334 | $109.70 | $366K | 70.2Kdirect | Aug 12, 2015 | Aug 14, 2015 | Form 4 ↗ |
| Aliski WilliamDirector | Sale | −400 | $122.58 | $49K | 109.0Kindirect | Jul 27, 2015 | Oct 9, 2018 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →